This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

10 Apr 2014

CPHI Russia 2014 Helps Regional Market Grow at over 10% Annually

Leading events organizer, UBM Live, along with partner RESTEC, announces that CPHI Russia @ IPhEB is returning for a second year to St. Petersburg, 16&17 April 2014. The event will co-locate with ICSE, P-MEC and InnoPack, creating Russia’s most comprehensive meeting point for the pharmaceutical industry. 


The Russian pharmaceutical market is one of the fastest developing, currently growing at double the rate of the global pharmaceutical market (more than 10% annually). Russia is benefiting from a growing economy and with the increased healthcare investments being made by the government, the market is set to enjoy a sustained and prolonged period of expansion. CPHI Russia @ IPhEB and its co-located events provide the ideal platform to break into this attractive region, with both domestic and international buyers and suppliers all looking to meet, network and drive the Russian market. 


This year’s platinum partner, JSC “Pharmasyntez” exemplifies the growth in the region, through their multi-million dollar investments in domestic drug production, with three new sites opening in 2014. The company will feature as an exhibitor at the event, showcasing their new dosage form capabilities- sterile powders and solutions for injection.


Alongside JSC 'Pharmasyntez', the total number of exhibitors vastly exceeds that of last year, rising from 65 exhibitors to more than 200. The exhibition moves to the Lenexpo Exhibition Complex to further facilitate the high levels of growth and mirroring the expanding domestic market. 


Highlights of CPHI Russia 2014:

• 2-day forum running alongside the exhibition, featuring highly valuable modules including ‘An Overview of Pharmaceutical and Medical Industries: State Priorities and Prospects for Development’ and ‘Doing Business In Russia — Market Access Considerations’


• Matchmaking programme for both visitors and exhibitors providing direct access to individual companies matching your business needs


• Exhibitor presentations showcasing latest news and product portfolios


• Bespoke mobile app, designed to ease on-site navigation and featuring complete exhibitor list, floor plan and forum schedule


“The Russian pharmaceutical market is experiencing a grand period of expansion, 4 years into its Pharma 2020 plan. With increased support from the government, coupled with the desire to increase domestic production by 50%, the Russian pharma landscape is proving to be a very attractive venture for international buyers and suppliers looking to break into this market. CPHI Russia plays a very important role within the region to accelerate this growth and further drive innovation within the market — a key goal within the country’s plan,” Erik Heemskerk, Brand Director Pharma.

Related News